Home/Filings/4/0001181431-11-023812
4//SEC Filing

METCALF BRIAN W 4

Accession 0001181431-11-023812

CIK 0000879169other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 4:09 PM ET

Size

11.6 KB

Accession

0001181431-11-023812

Insider Transaction Report

Form 4
Period: 2011-04-11
METCALF BRIAN W
Chief Drug Discovery Scientist
Transactions
  • Sale

    Common Stock

    2011-04-11$17.42/sh50,000$871,00066,504 total
  • Sale

    Common Stock

    2011-04-11$17.40/sh50,000$870,000116,504 total
  • Exercise/Conversion

    Non Qualified Stock Option (right to buy)

    2011-04-1182,6880 total
    Exercise: $5.46Exp: 2016-01-12Common Stock (82,688 underlying)
  • Exercise/Conversion

    Common Stock

    2011-04-11$5.46/sh+100,000$546,000166,504 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-04-1117,3120 total
    Exercise: $5.46Exp: 2016-01-12Common Stock (17,312 underlying)
Footnotes (1)
  • [F1]Beginning January 13, 2006, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Documents

1 file

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001234564

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 4:09 PM ET
Size
11.6 KB